Novo Nordisk has the potential to maintain more consistent revenue growth throughout next year. There is an indication that ...

New research reveals that taking a GLP-1 can be equivalent to '10 years of ageing' on the body, if proper precautions aren't taken ...

One in 20 Brits taking Mounjaro or Wegovy weight loss medications have been advised to avoid festive foods like pigs in ...

New statistics show how we eat has fundamentally changed in the past 12 months - over half of us now substitute meals with ...

After weeks of speculation, Amy Schumer, 44, has accepted that her marriage of seven years to chef Chris Fischer, 45, is over.

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo Nordisk India for its proposed update to ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

Amy Schumer made the bombshell announcement that she is divorcing husband Chris Fischer amid reports of turmoil in their ...

YOU may be keen to shed pounds from your waistline with fat jabs, but forking out the monthly bill is less appealing – ...

But even as Ozempic enters India, there is a growing sense globally that Novo may have already lost the obesity drug war to Mounjaro, Eli Lilly’s blockbuster that has become India’s top-selling drug ...

The dramatic stock slump, which puts Novo Nordisk at a historically cheap valuation, reflects investor concern over future sales growth and competition, particularly from rival Eli Lilly & Co.

Novo Nordisk’s blockbuster diabetes drug, Ozempic, was officially launched in India on December 12. Unlike in the US and ...